help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferone, D.
Right arrow Articles by Hofland, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferone, D.
Right arrow Articles by Hofland, L. J.
Endocrinology Vol. 140, No. 1 373-380
Copyright © 1999 by The Endocrine Society


ARTICLES

In Vitro Characterization of Somatostatin Receptors in the Human Thymus and Effects of Somatostatin and Octreotide on Cultured Thymic Epithelial Cells

Diego Ferone, P. Martin van Hagen, Peter M. van Koetsveld, Joke Zuijderwijk, Diana M. Mooy, Elgin G. R. Lichtenauer-Kaligis, Annamaria Colao, Ad J. J. C. Bogers, Gaetano Lombardi, Steven W. J. Lamberts and Leo J. Hofland

Departments of Internal Medicine III (D.F., P.M.v.H., P.M.v.K., J.Z., D.M.M., E.G.R.L.-K.), Immunology (P.M.v.H.) and Cardiothoracic Surgery (A.J.J.C.B.), Erasmus University, Rotterdam, The Netherlands; and Department of Molecular & Clinical Endocrinology and Oncology (D.F., A.C., G.L.), "Federico II" University, Naples, Italy

Address all correspondence and requests for reprints to: Leo J. Hofland, University Hospital Dijkzigt, Department of Internal Medicine III, Room Bd277, Dr Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands. E-mail: hofland{at}inw3.azr.nl

Somatostatin (SS) and its analogs exert inhibitory effects on secretive and proliferative processes of various cells via high affinity SS receptors (SS-R). SS analogs bind with different affinity to the five cloned SS-R subtypes. Octreotide, an octapeptide SS analog, binds with high affinity to the SS-R subtype 2 (sst2). SS-R have been demonstrated in vivo and in vitro on cells from endocrine and immune systems. Among the lymphatic tissues, the thymus has been shown to contain the highest amount of SS, suggesting a local functional role of the peptide.

We investigated the SS distribution and SS-R expression pattern in the normal human thymus using autoradiography, membrane homogenate binding studies, and RT-PCR. In addition, the effect of SS and octreotide on growth of cultured thymic epithelial cells (TEC) was studied.

By autoradiography, binding of [125I-Tyr0]-SS-28 and [125I-Tyr3]-octreotide was detected in all seven thymuses studied. Specific [125I-Tyr3]-octreotide binding was shown on membrane preparations from thymuses, while not from cultured thymocytes. RT-PCR showed the expression of sst1, sst2A and sst3 messenger RNA (mRNA) in the thymic tissue, whereas sst1 and sst2A mRNAs were found in isolated TEC. SS mRNA was present in thymic tissue and in isolated TEC. SS and octreotide significantly inhibited 3H-thymidine incorporation in 3 of 3 and 6 of 6 TEC cultures, respectively. The percent inhibition ranged from 38.8 to 66.8% for SS and from 19.1 to 59.5% for octreotide.

In conclusion, SS mRNA and sst1, sst2A, and sst3 mRNAs are expressed in the normal human thymus. Cultured TEC selectively express sst1 and sst2A mRNA and respond in vitro to SS and octreotide administration with an inhibition of cell proliferation. These data suggest a paracrine/autocrine role of SS and its receptors in the regulation of cell growth in thymic microenvironment.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
E. Resmini, P. Dadati, J.-L. Ravetti, G. Zona, R. Spaziante, A. Saveanu, P. Jaquet, M. D. Culler, F. Bianchi, A. Rebora, et al.
Rapid Pituitary Tumor Shrinkage with Dissociation between Antiproliferative and Antisecretory Effects of a Long-Acting Octreotide in an Acromegalic Patient
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1592 - 1599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Ferone, M. Arvigo, C. Semino, P. Jaquet, A. Saveanu, J. E. Taylor, J.-P. Moreau, M. D. Culler, M. Albertelli, F. Minuto, et al.
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1044 - E1050.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. J Hofland, J. van der Hoek, R. Feelders, M. O van Aken, P. M van Koetsveld, M. Waaijers, D. Sprij-Mooij, C. Bruns, G. Weckbecker, W. W de Herder, et al.
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
Eur. J. Endocrinol., April 1, 2005; 152(4): 645 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Pivonello, D. Ferone, W. W. de Herder, R. R. de Krijger, M. Waaijers, D. M. Mooij, P. M. van Koetsveld, A. Barreca, M. L. Del Basso De Caro, G. Lombardi, et al.
Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4493 - 4502.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Pivonello, D. Ferone, W. W. de Herder, J. M. Kros, M. L. Del Basso De Caro, M. Arvigo, L. Annunziato, G. Lombardi, A. Colao, L. J. Hofland, et al.
Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2452 - 2462.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. J. Loehrer Sr, W. Wang, D. H. Johnson, and D. S. Ettinger
Octreotide Alone or With Prednisone in Patients With Advanced Thymoma and Thymic Carcinoma: An Eastern Cooperative Oncology Group Phase II Trial
J. Clin. Oncol., January 15, 2004; 22(2): 293 - 299.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
V. A.S.H. Dalm, L. J. Hofland, C. M. Mooy, M. A. Waaijers, P. M. van Koetsveld, A. W. Langerak, F. T.J. Staal, A.-J. van der Lely, S. W.J. Lamberts, and M. P. van Hagen
Somatostatin Receptors in Malignant Lymphomas: Targets for Radiotherapy?
J. Nucl. Med., January 1, 2004; 45(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. J. Hofland, S. W.J. Lamberts, P. M. van Hagen, J.-C. Reubi, J. Schaeffer, M. Waaijers, P. M. van Koetsveld, A. Srinivasan, E. P. Krenning, and W. A.P. Breeman
Crucial Role for Somatostatin Receptor Subtype 2 in Determining the Uptake of [111In-DTPA-D-Phe1]Octreotide in Somatostatin Receptor-Positive Organs
J. Nucl. Med., August 1, 2003; 44(8): 1315 - 1321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. A. S. H. Dalm, P. M. van Hagen, P. M. van Koetsveld, S. Achilefu, A. B. Houtsmuller, D. H. J. Pols, A.-J. van der Lely, S. W. J. Lamberts, and L. J. Hofland
Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E344 - E353.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. A. Dalm, P. M. van Hagen, P. M. van Koetsveld, A. W. Langerak, A.-J. van der Lely, S. W. Lamberts, and L. J. Hofland
Cortistatin Rather Than Somatostatin as a Potential Endogenous Ligand for Somatostatin Receptors in the Human Immune System
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Ferone, R. Pivonello, P. M. van Hagen, V. A. S. H. Dalm, E. G. R. Lichtenauer-Kaligis, M. Waaijers, P. M. van Koetsveld, D. M. Mooy, A. Colao, F. Minuto, et al.
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1056 - E1066.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. J. Olsen, G. Olson, S. M. Viselli, X. Gu, and W. J. Kovacs
Androgen Receptors in Thymic Epithelium Modulate Thymus Size and Thymocyte Development
Endocrinology, March 1, 2001; 142(3): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Ferone, R. Pivonello, P. M. Van Hagen, M. Waaijers, J. Zuijderwijk, A. Colao, G. Lombardi, A. J. J. C. Bogers, S. W. J. Lamberts, and L. J. Hofland
Age-related decrease of somatostatin receptor number in the normal human thymus
Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E791 - E798.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
W. Savino and M. Dardenne
Neuroendocrine Control of Thymus Physiology
Endocr. Rev., August 1, 2000; 21(4): 412 - 443.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. C. Lambooij, R. W. A. M. Kuijpers, E. G. R. van Lichtenauer–Kaligis, M. Kliffen, G. S. Baarsma, P. M. van Hagen, and C. M. Mooy
Somatostatin Receptor 2A Expression in Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2329 - 2335.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Ferone, M. P. van Hagen, D. J. Kwekkeboom, P. M. van Koetsveld, D. M. Mooy, E. Lichtenauer-Kaligis, A. Schönbrunn, A. Colao, S. W. J. Lamberts, and L. J. Hofland
Somatostatin Receptor Subtypes in Human Thymoma and Inhibition of Cell Proliferation by Octreotide in Vitro
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1719 - 1726.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society